Wealthquest’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Wealthquest's BMY Position: Q2 2026 in Review
Wealthquest increased its Bristol-Myers Squibb (BMY) stake by 3.5% in Q2 2026, buying an estimated $11.7K and bringing the position to 6,075 shares worth $350K. The position accounts for 0.02% of the portfolio, ranked #124.
Wealthquest first reported a position in BMY in Q4 2018 and has held it in 25 quarters since. The position peaked at $361K in Q3 2023. 848 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Wealthquest held 6,075 shares of Bristol-Myers Squibb worth $350K as of Q2 2026.
- Wealthquest bought 204 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.7K.
- Bristol-Myers Squibb made up 0.02% of Wealthquest's portfolio in Q2 2026, its #124 holding.
- Wealthquest first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 25 quarters since.
- Wealthquest's Bristol-Myers Squibb position peaked at $361K in Q3 2023.
- 848 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Wealthquest's 13F filing for Q2 2026, filed 23 Jul 2026.